Song-Mei Liu

Song-Mei Liu

Auto-generated profile, based on publicly available information

Song-Mei Liu

Center for Gene Diagnosis, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, China

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 February 2014 in Molecules
Verified
Journal Article
Open access
PDF file
JWJin Wang
Jin Wang
JWJin Wang
Jin Wang
SLSong-Mei Liu
Song-Mei Liu
SSSubrata Sen
Subrata Sen
MicroRNAs (miRNAs), the 17- to 25-nucleotide long noncoding RNAs that modulate the expression of mRNAs and proteins, have emerged as critical players in cancer initiation and progression processes. Deregulation of tissue miRNA expression levels associated with specific genetic alterations has been demonstrated in cancer, where miRNAs function either as oncogenes or as tumor-suppressor genes and are shed from cancer cells into circulation. The present review summarizes and evaluates recent advances in our understanding of the characteristics of tumor tissue miRNAs, circulating miRNAs, and the stability of miRNAs in tissues and their varying expression profiles in circulating tumor cells, and body fluids including blood plasma. These advances in knowledge have led to intense efforts towards discovery and validation of differentially expressing tumor-associated miRNAs as biomarkers and therapeutic targets of cancer. The development of tumor-specific miRNA signatures as cancer biomarkers detectable in malignant cells and body fluids should help with early detection and more effective therapeutic intervention for individual patients.

28 December 2011 in Diabetic Medicine
Verified
Journal Article
Closed access
PDF file
FXF. X. Xu
F. X. Xu
XZX. Zhou
X. Zhou
FSFan Shen
Fan Shen
RPR. Pang
R. Pang
SLS. M. Liu
S. M. Liu

1 May 2012 in Gene
Verified
Journal Article
Closed access
SLSong-Mei Liu
Song-Mei Liu
FXFeng-Xia Xu
Feng-Xia Xu
FSFan Shen
Fan Shen
YXYan Xie
Yan Xie

15 October 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
FSFan Shen
Fan Shen
WHWei Huang
Wei Huang
JQJia-Hui Qi
Jia-Hui Qi
BYBi-Feng Yuan
Bi-Feng Yuan
JHJing-Tao Huang
Jing-Tao Huang
SLSong-Mei Liu
Song-Mei Liu
Increasing epidemiological evidence has indicated that inherited variations of mitochondrial DNA (mtDNA) copy number affect the genetic susceptibility of many malignancies in a tumour-specific manner and that DNA methylation also plays an important role in controlling gene expression during the differentiation and development of hepatocellular carcinoma (HCC). Our previous study demonstrated that HCC tissues showed a lower 5-hydroxymethylcytosine (5-hmC) content when compared to tumour-adjacent tissues, but the relationship among 5-hmC, 5-methylcytosine (5-mC) and mtDNA content in HCC patients is still unknown. This study aimed to clarify the correlation among mtDNA content, 5-mC and 5-hmC by quantitative real-time PCR and liquid chromatography tandem mass spectrometry analysis. We demonstrated that 5-hmC correlated with tumour size [odds ratio (OR) 0.847, 95% confidence interval (CI) 0.746–0.962, P = 0.011], and HCC patients with a tumour size ≥5.0 cm showed a lower 5-hmC content and higher levels of fasting plasma aspartate aminotransferase, the ratio of alanine amiotransferase to aspartate aminotransferase, γ-glutamyltransferase, alpha-fetoprotein than those with a tumour size <5 cm (all P<0.05). We further revealed that the mtDNA content of HCC tumour tissues was 225.97(105.42, 430.54) [median (25th Percentile, 75th Percentile)] and was negatively correlated with 5-mC content (P = 0.035), but not 5-hmC content, in genomic DNA from HCC tumour tissues.